Neuroone Medical Technologies Corp expected to post a loss of 20 cents a share - Earnings Preview

Neuroone Medical Technologies

12/08/2023 03:05

* Neuroone Medical Technologies Corp  NMTC.OQ   NMTC.O  is
expected to show a rise in quarterly revenue when it reports 
results on August 14. 
    * The Eden Prairie Minnesota-based  company is expected to
report 
a 993.8% increase in revenue to $350 thousand from $32 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Neuroone Medical
Technologies Corp is for a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63​, above​ its last closing price
of $1.07. ​​​

This summary was machine generated August 12 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated